Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px
Document › Details

Consilium Strategic Communications Ltd.. (4/9/18). "Press Release: Consilium Strategic Communications Appoints GSK’s David Daley as Senior Associate Partner". London.

Organisations Organisation Consilium Strategic Communications Ltd. (CSC)
  Organisation 2 GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
  Group GlaxoSmithKline (GSK) (Group)
Products Product public relations / investor relations (services)
  Product 2 pharmaceutical
Persons Person Daley, David (Consilium Strategic Communications 201806– before GSK for 8 years)
  Person 2 Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications)
     


Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, today announces that David Daley will join the team as a Senior Associate Partner following eight years at GSK. David is currently a Director in the Global Corporate Media Relations team at GSK and will join Consilium in June 2018.

David has more than 15 years’ experience in healthcare communications across the corporate and public sector, including global pharmaceuticals, public health policy and medicines regulation. He has led global corporate media relations strategies and healthcare communications campaigns aligned to organisational business objectives. He brings extensive crisis management experience gained during periods of intense public scrutiny. David has a degree in Biochemistry from University College London.

“David brings very relevant experience to Consilium from his time at GSK and in healthcare communications roles in government, and we look forward to introducing him to our clients.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications

“Global life sciences and healthcare are fascinating sectors and I’m delighted to be joining Consilium, who are such respected leaders in these fields. I am beyond impressed with the expertise and energy of the team and look forward to joining them as the business continues its rapid growth.”
David Daley


For more information please contact:

Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
info@consilium-comms.com
www.consilium-comms.com

Follow us: @consiliumhc


About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.

   
Record changed: 2018-04-16

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Consilium Strategic Communications Ltd. (CSC)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px




» top